Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma

NCT03266692 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Business reasons

Conditions

Multiple Myeloma
Multiple Myeloma in Relapse
Refractory Multiple Myeloma

Interventions

BIOLOGICAL: ACTR087
BIOLOGICAL: SEA-BCMA

Sponsor

Cogent Biosciences, Inc.

Collaborators

[object Object]